(Q34347517)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author

Adriana Aguilar-Lemarroy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Angel H Alvarez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Abel Gutiérrez-Ortega

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Luis Felipe Jave-suarez

1 reference

ORCID Public Data File 2021

author name string

Eneida López-Árias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Luis Felipe Jave-Suárez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Gilberto Morgan-Villela

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ignacio Mariscal-Ramírez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Moisés Martínez-Velázquez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Rodolfo Hernández-Gutiérrez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

2130-2137

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22821488%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Trends in breast cancer incidence, survival, and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Human body fluid proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Cancer immunomics using autoantibody signatures for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Serum autoantibodies as biomarkers for early cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Role of HER2 gene overexpression in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Novel Proteomic Strategy Reveal Combined α1 Antitrypsin and Cathepsin D as Biomarkers for Colorectal Cancer Early Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

Autoantibodies in breast cancer: their use as an aid to early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

7 January 2021

Anti-p53 in Breast Cancer: Concordance of Different Assay Procedures and Association with p53 Antigen Expression

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

7 January 2021

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

7 January 2021

HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201100491

7 January 2021